Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Works matching IS 18696953 AND DT 2021 AND VI 12 AND IP 6
Results: 13
1
2
Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 6, p. 1735, doi. 10.1007/s13300-021-01072-4
- By:
- Publication type:
- Article
3
Favorable Effects of 24‐Week Whole-Body Vibration on Glycemic Control and Comprehensive Diabetes Therapy in Elderly Patients with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 6, p. 1751, doi. 10.1007/s13300-021-01068-0
- By:
- Publication type:
- Article
4
Descriptive Regional Subanalysis of a Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide MR During Fasting: DIA-RAMADAN.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 6, p. 1703, doi. 10.1007/s13300-021-01067-1
- By:
- Publication type:
- Article
5
Risk Prediction Model of Gestational Diabetes Mellitus in a Chinese Population Based on a Risk Scoring System.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 6, p. 1721, doi. 10.1007/s13300-021-01066-2
- By:
- Publication type:
- Article
6
New Sub-Phenotyping of Subjects at High Risk of Type 2 Diabetes: What Are the Potential Clinical Implications?
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 6, p. 1605, doi. 10.1007/s13300-021-01065-3
- By:
- Publication type:
- Article
7
Evaluating the Effectiveness of Switching to Insulin Degludec from Other Basal Insulins in a Real-World Canadian Population with Type 1 or Type 2 Diabetes: The CAN-TREAT Study.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 6, p. 1689, doi. 10.1007/s13300-021-01063-5
- By:
- Publication type:
- Article
8
A Target HbA1c Between 7 and 7.7% Reduces Microvascular and Macrovascular Events in T2D Regardless of Duration of Diabetes: a Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 6, p. 1661, doi. 10.1007/s13300-021-01062-6
- By:
- Publication type:
- Article
9
One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 6, p. 1593, doi. 10.1007/s13300-021-01061-7
- By:
- Publication type:
- Article
10
Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 6, p. 1631, doi. 10.1007/s13300-021-01060-8
- By:
- Publication type:
- Article
11
Correction to: Injection Technique Education in Patients with Diabetes Injecting Insulin into Areas of Lipohypertrophy: A Randomized Controlled Trial.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
12
One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 6, p. 1677, doi. 10.1007/s13300-021-01056-4
- By:
- Publication type:
- Article
13
Importance of Early Screening and Diagnosis of Chronic Kidney Disease in Patients with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 6, p. 1613, doi. 10.1007/s13300-021-01050-w
- By:
- Publication type:
- Article